argenx SE | ARGX - Current Assets

Stock Price
712.80
Daily Change
-0.80 -0.11%
Monthly
4.27%
Yearly
12.89%
Q1 Forecast
686.63

argenx SE reported $5.83B in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
AstraZeneca USD 29.94B 1B Sep/2025
Galapagos EUR 3.16B 93.29M Sep/2025
Genmab DKK 3.91B 127M Jun/2025
GlaxoSmithKline GBP 17.84B 169M Sep/2025
GRIFOLS EUR 5.35B 102.57M Sep/2025
Hikma Pharmaceutical USD 2.56B 294M Jun/2025
Qiagen NV USD 2.53B 711.95M Sep/2025
UCB EUR 4.79B 1.47B Dec/2024